Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bojar

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Cancer Research|August 1, 1986
Quality control requirements in estrogen receptor determinationH Bojar
Anticancer Research|March 1, 1985
Dexamethasone, medroxyprogesterone acetate, and vindesine modulation of human malignant melanoma growth in soft agarH Bojar, W Fabry
Biochimica Et Biophysica Acta|June 30, 1985
Insulin effect on translational diffusion of lipids and proteins in the plasma membrane of isolated rat hepatocytesM Stuschke, H Bojar
Urologia Internationalis|January 1, 1980
The endocrine background of human renal cell carcinoma. V. Binding of the highly potent androgen methyltrienolone (R 1881) by tumour cytosolH Bojar, K Maar, W Staib
Urologia Internationalis|January 1, 1979
The endocrine background of human renal cell carcinoma. II. Attempt to induce the R-5020-binding components by oestrogensH Bojar, K Maar, W Staib
Urologia Internationalis|January 1, 1979
The endocrine background of human renal cell carcinoma. III. Role of inhibitors of R 5020 binding in tumour cytosolH Bojar, K Maar, W Staib
Anticancer Research|July 1, 1987
Differentiated DNA analysis in relation to steroid receptor status, grading, and staging in human breast cancerG Meckenstock, H Bojar, W Hort
Methods in Molecular Medicine|March 11, 2011
Gene Therapy for Treatment of Brain Tumors (HSV-tKIn Vivo Gene Transfer) : A Case StudyF Weber, F Floeth, H Bojar
Urologia Internationalis|January 1, 1979
The endocrine background of human renal cell carcinoma. I. Binding of the highly potent progestin R 5020 by tumour cytosolH Bojar, K Maar, W Staib
Urologia Internationalis|January 1, 1979
The endocrine background of human renal cell carcinoma. IV. Glucocorticoid receptors as possible mediators of progestogen actionH Bojar, K Maar, W Staib
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Cancer Research|August 1, 1986
Quality control requirements in estrogen receptor determinationH Bojar
Anticancer Research|March 1, 1985
Dexamethasone, medroxyprogesterone acetate, and vindesine modulation of human malignant melanoma growth in soft agarH Bojar, W Fabry
Biochimica Et Biophysica Acta|June 30, 1985
Insulin effect on translational diffusion of lipids and proteins in the plasma membrane of isolated rat hepatocytesM Stuschke, H Bojar
Urologia Internationalis|January 1, 1980
The endocrine background of human renal cell carcinoma. V. Binding of the highly potent androgen methyltrienolone (R 1881) by tumour cytosolH Bojar, K Maar, W Staib
Urologia Internationalis|January 1, 1979
The endocrine background of human renal cell carcinoma. II. Attempt to induce the R-5020-binding components by oestrogensH Bojar, K Maar, W Staib
Urologia Internationalis|January 1, 1979
The endocrine background of human renal cell carcinoma. III. Role of inhibitors of R 5020 binding in tumour cytosolH Bojar, K Maar, W Staib
Anticancer Research|July 1, 1987
Differentiated DNA analysis in relation to steroid receptor status, grading, and staging in human breast cancerG Meckenstock, H Bojar, W Hort
Methods in Molecular Medicine|March 11, 2011
Gene Therapy for Treatment of Brain Tumors (HSV-tKIn Vivo Gene Transfer) : A Case StudyF Weber, F Floeth, H Bojar
Urologia Internationalis|January 1, 1979
The endocrine background of human renal cell carcinoma. I. Binding of the highly potent progestin R 5020 by tumour cytosolH Bojar, K Maar, W Staib
Urologia Internationalis|January 1, 1979
The endocrine background of human renal cell carcinoma. IV. Glucocorticoid receptors as possible mediators of progestogen actionH Bojar, K Maar, W Staib
Pageof 6